Literature DB >> 20424841

Enteroviruses in the pathogenesis of type 1 diabetes.

Sisko Tauriainen1, Sami Oikarinen, Maarit Oikarinen, Heikki Hyöty.   

Abstract

The question if enteroviruses could cause beta-cell damage and type 1 diabetes has become more and more relevant when recent studies have provided new evidence supporting this scenario. One important observation is the recent discovery of IFIH1 as a risk gene for type 1 diabetes. This gene is an innate immune system receptor for enteroviruses offering one possible mechanism for the diabetogenic effect of enteroviruses. This is further emphasized by the observations suggesting that the innate immune system is activated in the pancreatic islets of type 1 diabetic patients and that the innate immune system is important for the defense against the virus and for the regulation of adaptive immune system. Important progress has also been gained in studies analyzing pancreas tissue for possible presence of enteroviruses. Several studies have found enteroviruses in the pancreatic islets of type 1 diabetic patients using various methods. The virus seems to be located in the islets while exocrine pancreas is mostly uninfected. One recent study found the virus in the intestinal mucosa in the majority of diabetic patients. Enteroviruses can also infect cultured human pancreatic islets causing either rapid cell destruction or a persistent-like noncytolytic infection. Combined with all previous, epidemiological findings indicating the risk effect of enteroviruses in cross-sectional and prospective studies, these observations fit to a scenario where certain diabetogenic enterovirus variants establish persistent infection in gut mucosa and in the pancreatic islets. This in turn could lead to a local inflammation and the breakdown of tolerance in genetically susceptible individuals. This is also supported by mouse experiments showing that enteroviruses can establish prolonged infection in the pancreas and intestine, and some virus strains cause beta-cell damage and diabetes. In conclusion, recent studies have strengthened the hypothesis that enteroviruses play a role in the pathogenesis of type 1 diabetes. These findings open also new opportunities to explore the underlying mechanism and get closer to causal relationship.

Entities:  

Mesh:

Year:  2010        PMID: 20424841     DOI: 10.1007/s00281-010-0207-y

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  80 in total

1.  Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection.

Authors:  W Chehadeh; J Weill; M C Vantyghem; G Alm; J Lefèbvre; P Wattré; D Hober
Journal:  J Infect Dis       Date:  2000-06-05       Impact factor: 5.226

Review 2.  Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes.

Authors:  Martin J Richer; Marc S Horwitz
Journal:  Autoimmun Rev       Date:  2009-02-11       Impact factor: 9.754

3.  Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus.

Authors:  H S Jun; Y Kang; A L Notkins; J W Yoon
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

Review 4.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

5.  Complete nucleotide sequence of a Coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology.

Authors:  Hong Yin; Anna-Karin Berg; Jan Westman; Claes Hellerström; Gun Frisk
Journal:  J Med Virol       Date:  2002-12       Impact factor: 2.327

6.  Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study.

Authors:  M Lönnrot; K Korpela; M Knip; J Ilonen; O Simell; S Korhonen; K Savola; P Muona; T Simell; P Koskela; H Hyöty
Journal:  Diabetes       Date:  2000-08       Impact factor: 9.461

7.  Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus.

Authors:  L Hermitte; B Vialettes; P Naquet; C Atlan; M J Payan; P Vague
Journal:  Eur J Immunol       Date:  1990-06       Impact factor: 5.532

8.  No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes.

Authors:  M Füchtenbusch; A Irnstetter; G Jäger; A G Ziegler
Journal:  J Autoimmun       Date:  2001-12       Impact factor: 7.094

9.  Detection of common viruses using the polymerase chain reaction to assess levels of viral presence in type 1 (insulin-dependent) diabetic patients.

Authors:  C A Foy; P Quirke; F A Lewis; T S Futers; H J Bodansky
Journal:  Diabet Med       Date:  1995-11       Impact factor: 4.359

10.  Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice.

Authors:  Christophe M Filippi; Elizabeth A Estes; Janine E Oldham; Matthias G von Herrath
Journal:  J Clin Invest       Date:  2009-05-26       Impact factor: 14.808

View more
  46 in total

Review 1.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes.

Authors:  K Lind; M H Hühn; M Flodström-Tullberg
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 2.  Environmental triggers of type 1 diabetes.

Authors:  Mikael Knip; Olli Simell
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  Novel gene associations in type 1 diabetes.

Authors:  Jorma Ilonen; Robert Hermann
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

4.  Experience of a serious life event increases the risk for childhood type 1 diabetes: the ABIS population-based prospective cohort study.

Authors:  Maria Nygren; John Carstensen; Felix Koch; Johnny Ludvigsson; Anneli Frostell
Journal:  Diabetologia       Date:  2015-04-14       Impact factor: 10.122

5.  Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes.

Authors:  H-S Lee; T Briese; C Winkler; M Rewers; E Bonifacio; H Hyoty; M Pflueger; O Simell; J X She; W Hagopian; Å Lernmark; B Akolkar; J Krischer; A G Ziegler
Journal:  Diabetologia       Date:  2013-05-09       Impact factor: 10.122

Review 6.  Genome-virome interactions: examining the role of common viral infections in complex disease.

Authors:  Ellen F Foxman; Akiko Iwasaki
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

Review 7.  The virome in host health and disease.

Authors:  Ken Cadwell
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

Review 8.  The impact of anti-inflammatory cytokines on the pancreatic β-cell.

Authors:  M A Russell; N G Morgan
Journal:  Islets       Date:  2014       Impact factor: 2.694

Review 9.  The pathogenesis and natural history of type 1 diabetes.

Authors:  Mark A Atkinson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

Review 10.  Virus infections as potential targets of preventive treatments for type 1 diabetes.

Authors:  Noora Nurminen; Sami Oikarinen; Heikki Hyöty
Journal:  Rev Diabet Stud       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.